THE GREEN SMOOTHIE FAD: THIS ROAD TO HEALTH HELL IS PAVED WITH TOXIC OXALATE CRYSTALS
by William Shaw, PhD Townsend Letter, January 2015
glass of green smoothie

Figure 1: Summary of Oxalate Sources. Candida albicans can produce an enzyme called collagenase that breaks down collagen, a major human body protein that makes up 30% of our proteins. In addition, ethylene glycol (antifreeze) is converted to oxalate by human enzymes. Many fungi, including those that infect humans, also produce oxalates directly, and oxalate stones may be found in tissues such as the lung and sinuses that are fungi infected. Vitamin C (ascorbic acid), especially at doses of more than 2000 mg per day, can break down to form oxalates, and certain fungi can convert the Candida byproduct arabinose to oxalate. Collagenase breaks down collagen to form hydroxyproline, one of collagen’s major amino acids. Hydroxyproline is also a major constituent of gelatin, a popular dessert. Hydroxyproline can then be converted to glycolate and glyoxylate by a series of reactions in the human body. Further metabolism of glyoxylate is at a critical junction. If adequate amounts of vitamin B6 are available, the enzyme AGT converts glyoxylate to the amino acid glycine. If vitamin B6 is deficient, glyoxylate is increasingly converted to oxalate by lactate dehydrogenase, although some of it is converted back to glycolate, which is again susceptible to forming additional oxalate.
Oxalic acid is the most acidic organic acid in body fluids and is used commercially to remove rust from car radiators. Antifreeze (ethylene glycol) is toxic primarily because it is converted to oxalate. Two different types of genetic diseases are known in which oxalates are high in the urine. The genetic types of hyperoxaluria (type I and type II) can be determined from the organic acid test done at the Great Plains Laboratory. Foods especially high in oxalates include spinach and similar leafy vegetables, beets, chocolate, soy, peanuts, wheat bran, tea, cashews, pecans, almonds, berries, and many others. Oxalates are not found in meat or fish at significant concentrations. Daily adult oxalate intake is usually 80 to 120 mg/d, but it can range from 44 to 1000 mg/d in individuals who eat a typical Western diet. I estimate that the person who consumes a green smoothie with 2 cups (about 150 grams) of spinach leaves is consuming about 15 grams (15,000 mg) of oxalates, or about 150 times the average daily oxalate intake. A complete list of high-oxalate foods is available on the Internet at http://www.upmc.com/patients-visitors/education/nutrition/pages/low-oxalate-diet.aspx. High oxalate in urine and plasma was first found in people who were susceptible to kidney stones. Most kidney stones are composed of calcium oxalate. Stones can range in size from the diameter of a grain of rice to the width of a golf ball. It is estimated that 10% of males may have kidney stones some time in their lives. Because many kidney stones contain calcium, some people with kidney stones think that they should avoid calcium supplements. However, the opposite is true. When calcium and magnesium are taken with foods high in oxalates, oxalic acid in the intestine combines with these minerals to form insoluble calcium and magnesium oxalate crystals that are eliminated in the stool. These forms of oxalate cannot be absorbed into the body. When calcium and/or magnesium are low in the diet, oxalic acid is soluble in the liquid portion of the contents of the intestine (called chyme) and is readily absorbed from the intestine into the bloodstream. If oxalic acid is very high in the blood being filtered by the kidney, it may combine with calcium and other metals, including heavy metals such as lead and mercury, to form crystals that may block urine flow, damage the kidney, and cause severe pain. These oxalate crystals can also form in the bones, skin, joints, eyes, thyroid gland, blood vessels, lungs, and even the brain.11–14 Oxalate crystals in the bone may crowd out the bone marrow cells, leading to anemia and immunosuppression.14 In addition to individuals with autism and kidney disease, individuals with fibromyalgia and women with vulvar pain (vulvodynia) may also suffer from the effects of excess oxalates.15–18 Recent evidence also points to the involvement of oxalates in stroke, atherosclerosis, and endothelial cell dysfunction.19–21 High amounts of oxalates were found concentrated in atherosclerotic lesions of the aortas and coronary arteries of a number of individuals at autopsy. These individuals did not have oxalate deposits in the kidney but did have oxalate deposits in other organs such as the thyroid gland and testes. Since the stains used by most pathologists examining atherosclerotic lesions cannot readily determine the presence of oxalates in diseased arteries, it seems possible that this cause of atherosclerosis may be much more common than previously realized. I suspect that oxalates are a much more common cause of atherosclerosis than high cholesterol. Furthermore, since ethylenediaminetetraacetic acid (EDTA) is effective in the removal of oxalate crystals deposited in the tissues, the benefits of intravenous EDTA in the treatment of cardiovascular disease may be mediated largely by the removal of oxalate crystals and their associated heavy metals from the tissues in which they are deposited.22,23 Oxalate crystals may cause damage to various tissues due to their sharp physical structure and they may increase inflammation. Iron oxalate crystals may also cause significant oxidative damage and diminish iron stores needed for red blood cell formation.11 Oxalates may also function as chelating agents and may chelate many toxic metals such as mercury and lead. However, unlike common chelating agents such as EDTA and DMSA that cause metals to be excreted, a reaction of oxalate with heavy metals such as mercury and lead leads to the precipitation of the heavy metal oxalate complex in the tissues, increasing the toxicity of heavy metals by delaying their excretion.24 What steps can be taken to control excessive oxalates?- Use antifungal drugs to reduce yeast and fungi that may be causing high oxalates. Children with autism frequently require years of antifungal treatment. I have noticed that arabinose, a marker indicating yeast/fungal overgrowth on the organic acid test at the Great Plains Laboratory, is correlated with high amounts of oxalates (Figure 1). Candida albicansproduces high amounts of the enzyme collagenase, which breaks down collagen in the gastrointestinal tract to form the amino acid hydroxyproline, which in a series of reactions is converted to oxalates, especially in people with low vitamin B6.25 Candida organisms have also been found surrounding oxalate stones in the kidney.10
- Give supplements of calcium citrate and magnesium citrate to reduce oxalate absorption from the intestine. Citrate is the preferred calcium form to reduce oxalate because citrate also inhibits oxalate absorption from the intestinal tract. The best way to administer calcium citrate would be to give it with each meal. Children over age 2 need about 1000 mg of calcium per day. Of course, calcium supplementation may need to be increased if the child is on a milk-free diet. The most serious error in adopting the gluten-free, casein-free diet is the failure to adequately supplement with calcium.
- Give chondroitin sulfate to prevent the formation of calcium oxalate crystals.26
- Vitamin B6 is a cofactor for one of the enzymes that degrades oxalate in the body and has been shown to reduce oxalate production.27
- Increase water intake to help eliminate oxalates.
- Consume a low-oxalate diet, avoiding high-oxalate foods such as leafy greens, beans, berries, nuts, tea, chocolate, wheat germ, and soy. Dr. Clare Morrison, a general pratitioner from the UK who has fibromyalgia, found relief from symptoms after changing to a low-oxalate diet. In a 2012 article in the Daily Mail, she said, “I cut these out of my diet and overnight my symptoms disappeared – the disabling muscle pains, tingling legs, fatigue and inability to concentrate all went.”28
1. Kohmani EF. Oxalic acid in foods and its behavior and fate in the diet. J Nutr. 1939;18(3):233–246. 2. Tsao G. Production of oxalic acid by a wood-rotting fungus. Appl Microbiol. 1963 May;11(3):249–254. 3. Takeuchi H, Konishi T, Tomoyoshi T. Observation on fungi within urinary stones.Hinyokika Kiyo. 1987;May;33(5):658–661. 4. Lee SH, Barnes WG, Schaetzel WP. Pulmonary aspergillosis and the importance of oxalate crystal recognition in cytology specimens. Arch Pathol Lab Med. 1986;Dec;110(12):1176–1179. 5. Muntz FH. Oxalate-producing pulmonary aspergillosis in an alpaca. Vet Pathol. 1999 Nov;36(6):631–632. 6. Loewus FA, Saito K, Suto RK, Maring E. Conversion of D-arabinose to D-erythroascorbic acid and oxalic acid in Sclerotinia sclerotiorum. Biochem Biophys Res Commun. 1995 Jul 6;212(1):196–203. 7. Fomina M, Hillier S, Charnock JM, Melville K, Alexander IJ, Gadd GM. Role of oxalic acid overexcretion in transformations of toxic metal minerals by Beauveria caledonica. Appl Environ Microbiol. 2005 Jan;71(1):371–381. 8. Ruijter GJG, van de Vondervoort PJI, Visser J. Oxalic acid production by Aspergillus niger: an oxalate-non-producing mutant produces citric acid at pH 5 and in the presence of manganese.Microbiology. 1999;145, 2569–2576. 9. Ghio AJ, Peterseim DS, Roggli VL, Piantadosi CA. Pulmonary oxalate deposition associated with Aspergillus niger infection. An oxidant hypothesis of toxicity. Am Rev Respir Dis. 1992 Jun;145(6):1499–1502. 10. Takeuchi H, Konishi T, Tomoyoshi T. Detection by light microscopy of Candida in thin sections of bladder stone. Urology. 1989 Dec;34(6):385–387. 11. Ghio AJ, Roggli VL, Kennedy TP, Piantadosi CA. Calcium oxalate and iron accumulation in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2000 Jun;17(2):140–150. 12. Ott SM, Andress DL, Sherrard DJ. Bone oxalate in a long-term hemodialysis patient who ingested high doses of vitamin C. Am J Kidney Dis. 1986 Dec;8(6):450–454. 13. Hall BM, Walsh JC, Horvath JS, Lytton DG. Peripheral neuropathy complicating primary hyperoxaluria. J Neurol Sci. 1976 Oct;29(2–4):343–349. 14. Sahin G, Acikalin MF, Yalcin AU. Erythropoietin resistance as a result of oxalosis in bone marrow. Clin Nephrol. (2005) May;63(5):402–404. 15. Sarma AV, Foxman B, Bayirli B, Haefner H, Sobel JD. Epidemiology of vulvar vestibulitis syndrome: an exploratory case-control study. Sex Transm Infect. (1999) Oct;75(5):320–326. 16. Guaifenesin, fibromyalgia and oxalates [blog post]. Aussie Mum/Wise Witch.http://wisewitch.blogspot.com/2006/07/guaifenesinfibromyalgia-and-oxalates.html. 17. Vulvadynia/vestibulitis: overview [Web page]. DiagnoseMe.com. http://www.diagnose-me.com/symptoms-of/vulvodynia-vestibulitis.html. 18. Solomon C. Low oxalate treatment [online article]. Vulvar Pain Foundation.http://www.vulvarpainfoundation.org/Lowoxalatetreatment.htm. 19. Fishbein GA, Micheletti RG, Currier JS, Singer E, Fishbein MC. Atherosclerotic oxalosis in coronary arteries. Cardiovasc Pathol. (2008);17(2):117–123. 20. Levin RI, PW Kantoff, EA Jaffe. Uremic levels of oxalic acid suppress replication and migration of human endothelial cells. Arterioscler Thromb Vasc Biol. (1990);10:198–120. 21. Di Pasquale G, Ribani M, Andreoli A, Angelo Zampa G, Pinelli G. Cardioembolic stroke in primary oxalosis with cardiac involvement. Stroke. (1989);20:1403–1406. 22. Ziolkowski F, Perrin DD. Dissolution of urinary stones by calcium-chelating agents: A study using a model system. Invest Urol. (1977);Nov;15(3):208–211. 23. Burns JR, Cargill JG 3rd. Kinetics of dissolution of calcium oxalate calculi with calcium-chelating irrigating solutions. J Urol. (1987 )Mar;137(3):530–533. 24. Shaw W. Oxalates:test implications for yeast & heavy metals [online article]. The Great Plains Laboratory, Inc. http://www.greatplainslaboratory.com/home/eng/oxalates.asp. retrievedAccessed Oct. 16, 2014. 25. Kaminishi H, Hagihara Y, Hayashi S, Cho T. Isolation and characteristics of collagenolytic enzyme produced by Candida albicans. Infect Immun. (1986) August; 53(2):312–316. 26. Shirane Y, Kurokawa Y, Miyashita S, Komatsu H, Kagawa S. Study of inhibition mechanisms of glycosaminoglycans on calcium oxalate monohydrate crystals by atomic force microscopy. Urol Res. (1999) Dec; 27(6):426–431. 27. Chetyrkin SV, Kim D, Belmont JM, Scheinman JI, Hudson BG, Voziyan PA. Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria. Kidney Int. (2005) Jan;67(1):53-–60. 28. Morrison C. Ditch healthy berries to beat muscle pain: the eating plan that helped me cure my aches and pains [online article]. Daily Mail Online. August 13, 2012.http://www.dailymail.co.uk/health/article-2187890/Ditch-health-berries-beat-muscle-pain-The-eating-plan-helped-cure-aches-pains.html. Accessed November 21, 2014.
William Shaw, PhD, is board certified in the fields of clinical chemistry and toxicology by the American Board of Clinical Chemistry. Before he founded the Great Plains Laboratory Inc., Dr. Shaw worked for the Centers for Disease Control and Prevention (CDC), Children’s Mercy Hospital, University of Missouri at Kansas City School of Medicine, and Smith Kline Laboratories. He is the author of Biological Treatments for Autism and PDD, originally published in 1998, andAutism: Beyond the Basics, published in 2009. He is also a frequent speaker at conferences worldwide. He is the stepfather of a child with autism and has helped thousands of patients and medical practitioners to successfully improve the lives of people with autism, AD(H)D, Alzheimer’s disease, arthritis, bipolar disorder, chronic fatigue, depression, fibromyalgia, immune deficiencies, multiple sclerosis, OCD, Parkinson’s disease, seizure disorders, tic disorders, Tourette syndrome, and other serious conditions.